CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Danielle Pillsbury2024 年 5 月 7 日
CERTAINTY – China
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
Danielle Pillsbury2024 年 5 月 7 日
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Danielle Pillsbury2024 年 5 月 7 日
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. （纳斯达克股票代码：CERT), a…
Jim Gallagher2024 年 5 月 7 日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…
Jim Gallagher2024 年 5 月 6 日
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…
Jim Gallagher2024 年 5 月 6 日
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…
Danielle Pillsbury2024 年 5 月 3 日
